The global market for Lumefantrine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lumefantrine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumefantrine API.
The Lumefantrine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lumefantrine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lumefantrine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hunan Huateng Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
NEWEDGE Overseas
Mangalam Drugs & Organics
Supriya Lifescience
Bajaj Healthcare
Believe Pharma
Calyx Chemicals & Pharmaceuticals
HELM Portugal
Ipca Laboratories
Mylan Inc
Skant Healthcare
Solara Active Pharma Sciences
Vaishali Pharma
Vital Laboratories
by Type
0.98
0.99
Others
by Application
Tablets
Soft Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lumefantrine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lumefantrine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lumefantrine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Lumefantrine API Market Overview
1.1 Product Definition
1.2 Lumefantrine API by Type
1.2.1 Global Lumefantrine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Lumefantrine API by Application
1.3.1 Global Lumefantrine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Soft Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Lumefantrine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Lumefantrine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Lumefantrine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Lumefantrine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lumefantrine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Lumefantrine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Lumefantrine API, Industry Ranking, 2023 VS 2024
2.4 Global Lumefantrine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Lumefantrine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Lumefantrine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lumefantrine API, Product Offered and Application
2.8 Global Key Manufacturers of Lumefantrine API, Date of Enter into This Industry
2.9 Lumefantrine API Market Competitive Situation and Trends
2.9.1 Lumefantrine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lumefantrine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lumefantrine API Production by Region
3.1 Global Lumefantrine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Lumefantrine API Production Value by Region (2020-2031)
3.2.1 Global Lumefantrine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Lumefantrine API by Region (2026-2031)
3.3 Global Lumefantrine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Lumefantrine API Production Volume by Region (2020-2031)
3.4.1 Global Lumefantrine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Lumefantrine API by Region (2026-2031)
3.5 Global Lumefantrine API Market Price Analysis by Region (2020-2025)
3.6 Global Lumefantrine API Production and Value, Year-over-Year Growth
3.6.1 North America Lumefantrine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Lumefantrine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Lumefantrine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Lumefantrine API Production Value Estimates and Forecasts (2020-2031)
4 Lumefantrine API Consumption by Region
4.1 Global Lumefantrine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Lumefantrine API Consumption by Region (2020-2031)
4.2.1 Global Lumefantrine API Consumption by Region (2020-2025)
4.2.2 Global Lumefantrine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Lumefantrine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Lumefantrine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lumefantrine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Lumefantrine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lumefantrine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Lumefantrine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lumefantrine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Lumefantrine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Lumefantrine API Production by Type (2020-2031)
5.1.1 Global Lumefantrine API Production by Type (2020-2025)
5.1.2 Global Lumefantrine API Production by Type (2026-2031)
5.1.3 Global Lumefantrine API Production Market Share by Type (2020-2031)
5.2 Global Lumefantrine API Production Value by Type (2020-2031)
5.2.1 Global Lumefantrine API Production Value by Type (2020-2025)
5.2.2 Global Lumefantrine API Production Value by Type (2026-2031)
5.2.3 Global Lumefantrine API Production Value Market Share by Type (2020-2031)
5.3 Global Lumefantrine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Lumefantrine API Production by Application (2020-2031)
6.1.1 Global Lumefantrine API Production by Application (2020-2025)
6.1.2 Global Lumefantrine API Production by Application (2026-2031)
6.1.3 Global Lumefantrine API Production Market Share by Application (2020-2031)
6.2 Global Lumefantrine API Production Value by Application (2020-2031)
6.2.1 Global Lumefantrine API Production Value by Application (2020-2025)
6.2.2 Global Lumefantrine API Production Value by Application (2026-2031)
6.2.3 Global Lumefantrine API Production Value Market Share by Application (2020-2031)
6.3 Global Lumefantrine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hunan Huateng Pharmaceutical
7.1.1 Hunan Huateng Pharmaceutical Lumefantrine API Company Information
7.1.2 Hunan Huateng Pharmaceutical Lumefantrine API Product Portfolio
7.1.3 Hunan Huateng Pharmaceutical Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hunan Huateng Pharmaceutical Main Business and Markets Served
7.1.5 Hunan Huateng Pharmaceutical Recent Developments/Updates
7.2 Shanghai Desano Bio-Pharmaceutical
7.2.1 Shanghai Desano Bio-Pharmaceutical Lumefantrine API Company Information
7.2.2 Shanghai Desano Bio-Pharmaceutical Lumefantrine API Product Portfolio
7.2.3 Shanghai Desano Bio-Pharmaceutical Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shanghai Desano Bio-Pharmaceutical Main Business and Markets Served
7.2.5 Shanghai Desano Bio-Pharmaceutical Recent Developments/Updates
7.3 NEWEDGE Overseas
7.3.1 NEWEDGE Overseas Lumefantrine API Company Information
7.3.2 NEWEDGE Overseas Lumefantrine API Product Portfolio
7.3.3 NEWEDGE Overseas Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 NEWEDGE Overseas Main Business and Markets Served
7.3.5 NEWEDGE Overseas Recent Developments/Updates
7.4 Mangalam Drugs & Organics
7.4.1 Mangalam Drugs & Organics Lumefantrine API Company Information
7.4.2 Mangalam Drugs & Organics Lumefantrine API Product Portfolio
7.4.3 Mangalam Drugs & Organics Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Mangalam Drugs & Organics Main Business and Markets Served
7.4.5 Mangalam Drugs & Organics Recent Developments/Updates
7.5 Supriya Lifescience
7.5.1 Supriya Lifescience Lumefantrine API Company Information
7.5.2 Supriya Lifescience Lumefantrine API Product Portfolio
7.5.3 Supriya Lifescience Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Supriya Lifescience Main Business and Markets Served
7.5.5 Supriya Lifescience Recent Developments/Updates
7.6 Bajaj Healthcare
7.6.1 Bajaj Healthcare Lumefantrine API Company Information
7.6.2 Bajaj Healthcare Lumefantrine API Product Portfolio
7.6.3 Bajaj Healthcare Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Bajaj Healthcare Main Business and Markets Served
7.6.5 Bajaj Healthcare Recent Developments/Updates
7.7 Believe Pharma
7.7.1 Believe Pharma Lumefantrine API Company Information
7.7.2 Believe Pharma Lumefantrine API Product Portfolio
7.7.3 Believe Pharma Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Believe Pharma Main Business and Markets Served
7.7.5 Believe Pharma Recent Developments/Updates
7.8 Calyx Chemicals & Pharmaceuticals
7.8.1 Calyx Chemicals & Pharmaceuticals Lumefantrine API Company Information
7.8.2 Calyx Chemicals & Pharmaceuticals Lumefantrine API Product Portfolio
7.8.3 Calyx Chemicals & Pharmaceuticals Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Calyx Chemicals & Pharmaceuticals Main Business and Markets Served
7.8.5 Calyx Chemicals & Pharmaceuticals Recent Developments/Updates
7.9 HELM Portugal
7.9.1 HELM Portugal Lumefantrine API Company Information
7.9.2 HELM Portugal Lumefantrine API Product Portfolio
7.9.3 HELM Portugal Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 HELM Portugal Main Business and Markets Served
7.9.5 HELM Portugal Recent Developments/Updates
7.10 Ipca Laboratories
7.10.1 Ipca Laboratories Lumefantrine API Company Information
7.10.2 Ipca Laboratories Lumefantrine API Product Portfolio
7.10.3 Ipca Laboratories Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Ipca Laboratories Main Business and Markets Served
7.10.5 Ipca Laboratories Recent Developments/Updates
7.11 Mylan Inc
7.11.1 Mylan Inc Lumefantrine API Company Information
7.11.2 Mylan Inc Lumefantrine API Product Portfolio
7.11.3 Mylan Inc Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Mylan Inc Main Business and Markets Served
7.11.5 Mylan Inc Recent Developments/Updates
7.12 Skant Healthcare
7.12.1 Skant Healthcare Lumefantrine API Company Information
7.12.2 Skant Healthcare Lumefantrine API Product Portfolio
7.12.3 Skant Healthcare Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Skant Healthcare Main Business and Markets Served
7.12.5 Skant Healthcare Recent Developments/Updates
7.13 Solara Active Pharma Sciences
7.13.1 Solara Active Pharma Sciences Lumefantrine API Company Information
7.13.2 Solara Active Pharma Sciences Lumefantrine API Product Portfolio
7.13.3 Solara Active Pharma Sciences Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Solara Active Pharma Sciences Main Business and Markets Served
7.13.5 Solara Active Pharma Sciences Recent Developments/Updates
7.14 Vaishali Pharma
7.14.1 Vaishali Pharma Lumefantrine API Company Information
7.14.2 Vaishali Pharma Lumefantrine API Product Portfolio
7.14.3 Vaishali Pharma Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Vaishali Pharma Main Business and Markets Served
7.14.5 Vaishali Pharma Recent Developments/Updates
7.15 Vital Laboratories
7.15.1 Vital Laboratories Lumefantrine API Company Information
7.15.2 Vital Laboratories Lumefantrine API Product Portfolio
7.15.3 Vital Laboratories Lumefantrine API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Vital Laboratories Main Business and Markets Served
7.15.5 Vital Laboratories Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lumefantrine API Industry Chain Analysis
8.2 Lumefantrine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lumefantrine API Production Mode & Process Analysis
8.4 Lumefantrine API Sales and Marketing
8.4.1 Lumefantrine API Sales Channels
8.4.2 Lumefantrine API Distributors
8.5 Lumefantrine API Customer Analysis
9 Lumefantrine API Market Dynamics
9.1 Lumefantrine API Industry Trends
9.2 Lumefantrine API Market Drivers
9.3 Lumefantrine API Market Challenges
9.4 Lumefantrine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hunan Huateng Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
NEWEDGE Overseas
Mangalam Drugs & Organics
Supriya Lifescience
Bajaj Healthcare
Believe Pharma
Calyx Chemicals & Pharmaceuticals
HELM Portugal
Ipca Laboratories
Mylan Inc
Skant Healthcare
Solara Active Pharma Sciences
Vaishali Pharma
Vital Laboratories
听
听
*If Applicable.
